Semaglutide is typically taken once weekly as a subcutaneous injection
The z -scores were estimated for participants with at least one NTB subtest and at least two-thirds (9/14) of the ADAS-Cog subtests completed
This product is not a drug, food, or cosmetic, and is not intended for diagnostic, therapeutic, or in vivo human use
This work was financially supported in part by National Institutes of Health awards U01HG011715, R01HG009120 and R01MH115676
Rare but serious effects include pancreatitis, gallbladder disease, and, in rodents, C-cell hyperplasia
$390 every 4 weeks tirzepatide is a proven GLP-1 medication that helps regulate appetite, curb cravings, and support healthier metabolic function